rss
Thorax 2000;55:722 doi:10.1136/thorax.55.8.722c
  • Letters to the editor

Fluticasone in asthma

  1. JOHN W HONOUR, Reader in Steroid Endocrinology
  1. University College London Hospital
  2. London W1P 6DB
  3. UK
  4. email: john.honour{at}uclh.org

      The paper by Meijer et al 1 compares the effects of inhaled fluticasone propionate (2 mg and 0.5 mg daily) and oral steroids (prednisolone 30 mg daily) in patients with mild to moderate asthma. Many patients with severe asthma are dependent upon corticosteroids, although inhaled steroids can effectively replace oral prednisolone.2

      The biological effects of oral versus inhaled steroids can be compared in terms of lung function, airway responsiveness, and blood eosinophil number and activity, but suppression of the hypothalamic-pituitary-adrenal (HPA) axis is very difficult to assess. Prednisolone is so chemically similar to cortisol that most analytical methods (particularly radioimmunoassay, as used by Meijeret al) cannot distinguish between the two steroids. Although the authors attempted to overcome this problem, the correction of the measured level of cortisol for a potential cross reaction with prednisolone is not valid. If there is any possibility of cross reaction from other steroids, cortisol assays are only specific if performed using high performance liquid chromatography or mass spectrometry.3 It is therefore incorrect for the authors to conclude that cortisol levels after 30 mg oral prednisolone were comparable to those after inhaled fluticasone in a dose of 2 mg/day. The paper did not describe the precise dosages and timings for fluticasone or prednisolone administration and these could have large effects on 08.00 hour serum cortisol concentrations. The increased systemic effect of prednisolone compared with fluticasone is strongly supported by the significantly higher serum ECP level and blood eosinophil count.

      Many papers on the function of the HPA axis in the context of safety of oral and inhaled steroids fail to take account of the normal function of the axis, the way in which the axis is perturbed by exogenous steroids, and the best methods for testing the axis, particularly when patients are also taking oral corticosteroids. Care should be taken at the outset to select analytical methods appropriate to the design of such studies to avoid misinterpretation.

      References

      1. RONAL J MEIJER,
      2. HUIB A M KERSTJENS,
      3. DIRKJE S POSTMA
      1. Department of Pulmonary Diseases
      2. University Hospital Groningen
      3. 9700 RB Groningen
      4. The Netherlands
      5. email: h.a.m.kerstjens{at}int.azg.nl
      1. Dr H A M Kerstjens.

        authors' reply We thank Dr Honour for his valuable comments. We are currently in the process of re-analysing our samples by an HPLC method as suggested by him, but we have had problems finding a laboratory able to perform the HPLC measurements with the required quality. We would like to respond as soon as the data are available.

        Register for free content


        Free sample
        This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
        View free sample issue >>

        Free archive
        The full back archive is now available for Thorax. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
        Register to access the free archive >>

        Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.